Eric Pauls Named Chief Customer Officer at RQM+

RQM+ has appointed Eric Pauls as chief customer officer, a newly-created senior executive role. With a focus on customer experience and satisfaction, Pauls will steer the company’s global commercialization team, ensuring an alignment between organizational objectives and customer needs. 
 
“I’m thrilled to join the RQM+ team and to focus on creating growing value for our customers,” Pauls said. “I’m confident that with a dedicated team and a customer-centric approach, we will continue to lead in the medtech services industry.”
 
Based in Pittsburgh, Pauls brings more than two decades of executive sales and business development experience to help drive and support current and future growth. He most recently worked as a senior sales executive at Tactile Medical, where he was directly responsible for the P&L management, business development, portfolio expansion and annual operating plan. Pauls is known for his ability to serve as a trusted advisor to key customers, peers and his team. In his previous role as an executive sales leader of Philips, he was accountable for driving the annual operating plan, business development, sales excellence and operational compliance.
 
“We are excited to welcome Eric as our new chief customer officer,” CEO Margaret Keegan stated. “His commitment to building meaningful relationships and delivering tangible results is in complete harmony with our company values and goals. Eric brings decades of understanding of our customers and with him on board, we are confident in our ability to navigate the complexities of the medtech industry and deliver value to our customers and stakeholders.”
 
RQM+ is a medtech service provider offering consulting, clinical trial, lab, and reimbursement services, as well as technology solutions to support the entire product lifecycle. RQM+’s global team of clinical, technical, and industry experts push the boundaries of excellence. With more former U.S. Food and Drug Administration; Medicines, and Healthcare Products Regulatory Agency (MHRA); and notified body regulators than any other firm, the RQM+ team has deep expertise in all clinical specialties. The company offers a full complement of CRO services to progress medical devices, digital therapeutics, and diagnostics onto the market. In addition to early- and mid-stage medtech companies, RQM+ currently works with 19 of the top 20 medical device manufacturers and seven of the top 10 IVD companies.